Marker Therapeutics, Inc. (MRKR): Operating Income
-$12.89M
Year ended 2025-12-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$12.89M | n/m | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | -$11.12M | n/m | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | -$14.58M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$19.79M | n/c | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | -$39.48M | n/m | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | -$28.89M | n/m | 2022-03-17, From 2020-01-01 |
| 2019-12-31 | -$22.53M | n/m | 2021-03-09, From 2019-01-01 |
| 2018-12-31 | -$148.17M | n/m | 2020-03-12, From 2018-01-01 |
| 2017-12-31 | -$11.48M | n/c | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | -$8.49M | n/m | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | -$6.16M | n/m | 2017-03-14, From 2015-01-01 |
| 2014-12-31 | -$3.37M | n/m | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | -$2.66M | n/a | 2015-04-15, From 2013-01-01 |
| No annual figure between 2011-12-31 and 2013-12-31. | |||
| 2011-12-31 | -$3.32M | n/m | 2012-04-16, From 2011-01-01 |
| 2010-12-31 | -$5.47M | n/a | 2012-04-16, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | -$12.89M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$52.55M | n/m |
| CervoMed Inc. (CRVO) | 2025-12-31 | -$28.29M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$3.24M | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$4.39M | n/m |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | -$2.83M | n/m |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | -$18.05M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$160.36M | n/m |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$143.41M | n/m |
Compare MRKR, CAMP, CRVO, CPHI side by side · Screen every company in Pharmaceutical Preparations ↗